Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Int J Oncol
    November 2017
  1. ALONSO-GONZALEZ C, Menendez-Menendez J, Gonzalez-Gonzalez A, Gonzalez A, et al
    Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF7 human breast cancer cells.
    Int J Oncol. 2017 Nov 28. doi: 10.3892/ijo.2017.4213.
    >> Share

  2. SONNENBLICK A, Salgado R, Brohee S, Zahavi T, et al
    p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
    Int J Oncol. 2017 Nov 27. doi: 10.3892/ijo.2017.4212.
    >> Share

    October 2017
  3. RAMAN V, Fuentes Lorenzo JL, Stashenko EE, Levy M, et al
    Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-kappaB signaling in triple-negative breast cancer cells.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4169.
    >> Share

  4. BORAH N, Gunawardana S, Torres H, McDonnell S, et al
    5,6,7,3',4',5'-Hexamethoxyflavone inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle.
    Int J Oncol. 2017 Oct 13. doi: 10.3892/ijo.2017.4157.
    >> Share

  5. RATAJCZAK-WIELGOMAS K, Grzegrzolka J, Piotrowska A, Matkowski R, et al
    Expression of periostin in breast cancer cells.
    Int J Oncol. 2017;51:1300-1310.
    >> Share

  6. YIN H, Zhu Q, Liu M, Tu G, et al
    GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis.
    Int J Oncol. 2017;51:1191-1198.
    >> Share

  7. PHILLIPS SL, Williams CB, Zambrano JN, Williams CJ, et al
    Connexin 43 in the development and progression of breast cancer: What's the connection? (Review).
    Int J Oncol. 2017;51:1005-1013.
    >> Share

    September 2017
  8. YANG L, Li Y, Shen E, Cao F, et al
    NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
    Int J Oncol. 2017 Sep 21. doi: 10.3892/ijo.2017.4130.
    >> Share

  9. ESPINOZA-SANCHEZ NA, Vadillo E, Balandran JC, Monroy-Garcia A, et al
    Evidence of lateral transmission of aggressive features between different types of breast cancer cells.
    Int J Oncol. 2017 Sep 19. doi: 10.3892/ijo.2017.4128.
    >> Share

  10. CALAF GM, Roy D
    Metastatic genes targeted by an antioxidant in an established radiation- and estrogen-breast cancer model.
    Int J Oncol. 2017 Sep 14. doi: 10.3892/ijo.2017.4125.
    >> Share

  11. D'ANGELO S, Martino E, Ilisso CP, Bagarolo ML, et al
    Pro-oxidant and pro-apoptotic activity of polyphenol extract from Annurca apple and its underlying mechanisms in human breast cancer cells.
    Int J Oncol. 2017;51:939-948.
    >> Share

  12. OBAYASHI S, Horiguchi J, Higuchi T, Katayama A, et al
    Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
    Int J Oncol. 2017;51:781-790.
    >> Share

  13. [Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications.
    Int J Oncol. 2017;51:997-0.
    >> Share

    August 2017
  14. ILKOVICOVA L, Trost N, Szentpeteriova E, Solar P, et al
    Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen.
    Int J Oncol. 2017;51:737-746.
    >> Share

    July 2017
  15. WANG Y, Wang H, Ding Y, Li Y, et al
    N-peptide of vMIP- reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.
    Int J Oncol. 2017 Jul 19. doi: 10.3892/ijo.2017.4076.
    >> Share

  16. LI SJ, Liu CS, Li HJ, Li Y, et al
    A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy.
    Int J Oncol. 2017 Jul 3. doi: 10.3892/ijo.2017.4062.
    >> Share

    June 2017
  17. KIM DH, Sung B, Kim JA, Kang YJ, et al
    HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
    Int J Oncol. 2017 Jun 27. doi: 10.3892/ijo.2017.4058.
    >> Share

  18. NOWAK A, Grzegrzolka J, Paprocka M, Piotrowska A, et al
    Nestin-positive microvessel density is an independent prognostic factor in breast cancer.
    Int J Oncol. 2017 Jun 26. doi: 10.3892/ijo.2017.4057.
    >> Share

  19. YAO M, Yuan B, Wang X, Sato A, et al
    Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
    Int J Oncol. 2017 Jun 23. doi: 10.3892/ijo.2017.4052.
    >> Share

    May 2017
  20. LIANG N, Li Y, Chung HY
    Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4004.
    >> Share

  21. LINDSTEN T, Hedbrant A, Ramberg A, Wijkander J, et al
    Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3996.
    >> Share

  22. DING Y, Zhang C, Zhang J, Zhang N, et al
    miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-beta1 expression.
    Int J Oncol. 2017;50:1701-1710.
    >> Share

  23. NGUYEN CH, Huttary N, Atanasov AG, Chatuphonprasert W, et al
    Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.
    Int J Oncol. 2017;50:1879-1888.
    >> Share

    April 2017
  24. MCDERMOTT MSJ, Canonici A, Ivers L, Browne BC, et al
    Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells.
    Int J Oncol. 2017 Apr 26. doi: 10.3892/ijo.2017.3976.
    >> Share

    March 2017
  25. XI J, Feng J, Li Q, Li X, et al
    The long non-coding RNA lncFOXO1 suppresses growth of human breast cancer cells through association with BAP1.
    Int J Oncol. 2017 Mar 24. doi: 10.3892/ijo.2017.3933.
    >> Share

  26. OKAMOTO K, Tanaka Y, Tsuneoka M
    SF-KDM2A binds to ribosomal RNA gene promoter, reduces H4K20me3 level, and elevates ribosomal RNA transcription in breast cancer cells.
    Int J Oncol. 2017 Mar 10. doi: 10.3892/ijo.2017.3908.
    >> Share

  27. GIL EY, Jo UH, Jeong H, Whang YM, et al
    [Corrigendum] Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3900.
    >> Share

  28. ZHENG X, Wang C, Xing Y, Chen S, et al
    SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
    Int J Oncol. 2017;50:893-902.
    >> Share

    February 2017
  29. PANAGOPOULOS V, Leach DA, Zinonos I, Ponomarev V, et al
    Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3883.
    >> Share

  30. LANGO-CHAVARRIA M, Chimal-Ramirez GK, Ruiz-Tachiquin ME, Espinoza-Sanchez NA, et al
    A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients.
    Int J Oncol. 2017;50:432-440.
    >> Share

  31. GUERRIERO E, Sorice A, Capone F, Storti G, et al
    Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines.
    Int J Oncol. 2017;50:468-476.
    >> Share

    January 2017
  32. TRIANTAFILLU UL, Park S, Klaassen NL, Raddatz AD, et al
    Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
    Int J Oncol. 2017 Jan 30. doi: 10.3892/ijo.2017.3865.
    >> Share

  33. JIANG W, Li X, Li T, Wang H, et al
    Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.
    Int J Oncol. 2017 Jan 24. doi: 10.3892/ijo.2017.3860.
    >> Share

    December 2016
  34. MAXWELL T, Chun SY, Lee KS, Kim S, et al
    The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
    Int J Oncol. 2016 Dec 29. doi: 10.3892/ijo.2016.3825.
    >> Share

  35. NAKAYAMA J, Ito E, Fujimoto J, Watanabe S, et al
    Comparative analysis of gene regulatory networks of highly metastatic breast cancer cells established by orthotopic transplantation and intra-circulation injection.
    Int J Oncol. 2016 Dec 16. doi: 10.3892/ijo.2016.3809.
    >> Share

  36. PARK JH, Kim HK, Jung H, Kim KH, et al
    NecroX-5 prevents breast cancer metastasis by AKT inhibition via reducing intracellular calcium levels.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3789.
    >> Share

    November 2016
    miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.
    Int J Oncol. 2016 Nov 7. doi: 10.3892/ijo.2016.3761.
    >> Share

  38. GOMULKIEWICZ A, Jablonska K, Pula B, Grzegrzolka J, et al
    Expression of metallothionein 3 in ductal breast cancer.
    Int J Oncol. 2016 Nov 4. doi: 10.3892/ijo.2016.3759.
    >> Share

    October 2016
  39. ZHOU H, Li J, Zhang Z, Ye R, et al
    RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Int J Oncol. 2016 Oct 5. doi: 10.3892/ijo.2016.3718.
    >> Share

    September 2016
  40. MEJIA-RANGEL J, Cordova E, Orozco L, Ventura-Gallegos JL, et al
    Pro-adhesive phenotype of normal endothelial cells responding to metastatic breast cancer cell conditioned medium is linked to NFkappaB-mediated transcriptomic regulation.
    Int J Oncol. 2016 Sep 26. doi: 10.3892/ijo.2016.3705.
    >> Share

  41. DING J, Guo C, Hu P, Chen J, et al
    CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3680.
    >> Share

  42. LIU ZG, Tang J, Chen Z, Zhang H, et al
    The novel mTORC1/2 dual inhibitor INK128 enhances radiosensitivity of breast cancer cell line MCF-7.
    Int J Oncol. 2016;49:1039-45.
    >> Share

  43. ZHAO Q, Zhao M, Parris AB, Xing Y, et al
    Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
    Int J Oncol. 2016;49:1203-10.
    >> Share

  44. PARK JH, Cho YY, Yoon SW, Park B, et al
    Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-kappaB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
    Int J Oncol. 2016;49:1230-40.
    >> Share

  45. GALLARDO M, Calaf GM
    Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines.
    Int J Oncol. 2016;49:1019-27.
    >> Share

  46. IBRAHIM T, Liverani C, Mercatali L, Sacanna E, et al
    [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.
    Int J Oncol. 2016;49:1260.
    >> Share

  47. CHA J, Roomi MW, Kalinovsky T, Niedzwiecki A, et al
    Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.
    Int J Oncol. 2016;49:895-902.
    >> Share

  48. PARK HJ, Kim MK, Choi KS, Jeong JW, et al
    Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.
    Int J Oncol. 2016;49:934-42.
    >> Share

    August 2016
  49. MIYAHARA K, Kazama H, Kokuba H, Komatsu S, et al
    Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.
    Int J Oncol. 2016 Aug 29. doi: 10.3892/ijo.2016.3673.
    >> Share

  50. HE DX, Zhang GY, Gu XT, Mao AQ, et al
    Genome-wide profiling of long non-coding RNA expression patterns in anthracycline-resistant breast cancer cells.
    Int J Oncol. 2016 Aug 22. doi: 10.3892/ijo.2016.3665.
    >> Share

  51. KARIYA Y, Tatsuta T, Sugawara S, Kariya Y, et al
    RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3/7 signaling pathway in human breast cancer cells.
    Int J Oncol. 2016 Aug 11. doi: 10.3892/ijo.2016.3656.
    >> Share

  52. CHOI YJ, Heo K, Park HS, Yang KM, et al
    The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
    Int J Oncol. 2016 Aug 3. doi: 10.3892/ijo.2016.3647.
    >> Share

    July 2016
  53. XU H, Wu K, Tian Y, Liu Q, et al
    CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.
    Int J Oncol. 2016 Jul 29. doi: 10.3892/ijo.2016.3639.
    >> Share

  54. SULAIMAN NB, Mohan CD, Basappa S, Pandey V, et al
    An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway.
    Int J Oncol. 2016 Jul 6. doi: 10.3892/ijo.2016.3615.
    >> Share

    June 2016
  55. KIM B, Kim YC, Park B
    Pomolic acid inhibits metastasis of HER2 overexpressing breast cancer cells through inactivation of the ERK pathway.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3568.
    >> Share

    Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
    Int J Oncol. 2016 Jun 3. doi: 10.3892/ijo.2016.3558.
    >> Share

    May 2016
  57. PARK JH, Jang M, Tarhan YE, Katagiri T, et al
    Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
    Int J Oncol. 2016 May 27. doi: 10.3892/ijo.2016.3540.
    >> Share

  58. YAMAGUCHI M, Osuka S, Weitzmann MN, Shoji M, et al
    Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3538.
    >> Share

  59. MENG X, Hu B, Hossain MM, Chen G, et al
    ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3536.
    >> Share

  60. CHEN SY, Zheng XW, Cai JX, Zhang WP, et al
    Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.
    Int J Oncol. 2016 May 17. doi: 10.3892/ijo.2016.3528.
    >> Share

  61. WOODMAN N, Pinder SE, Tajadura V, Le Bourhis X, et al
    Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3521.
    >> Share

  62. KWON YS, Lee KS, Chun SY, Jang TJ, et al
    Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3520.
    >> Share

  63. GARCIA EP, Tiscornia I, Libisch G, Trajtenberg F, et al
    MUC5B silencing reduces chemo-resistance of MCF-7 breast tumor cells and impairs maturation of dendritic cells.
    Int J Oncol. 2016;48:2113-23.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016